Greenlight Capital Re Ltd

Greenlight Capital Re Ltd (GLRE) Stock Analysis

$15.370

-0.040 (-0.26%)At close

Loading chart…
High
15.460
Open
15.410
VWAP
15.38
Vol
147.29K
Mkt Cap
459.53M
Low
15.320
Amount
2.27M
EV/EBITDA, TTM
0.00

Greenlight Capital Re, Ltd provides multiline property and casualty insurance and reinsurance through its licensed and regulated reinsurance entities in the Cayman Islands and Ireland, and its Lloyd’s platform, Greenlight Innovation Syndicate 3456. The Company’s segments include Open Market and Innovations. In the Open Market segment, the Company underwrites reinsurance business, sourced through the brokerage distribution channels and Lloyd’s. The Company writes treaty reinsurance on a proportional and non-proportional basis. Its lines of business include casualty, financial, health, multiline, property and specialty. In the Innovations segment, the Company provides reinsurance capacity to startup companies and managing general agents (MGAs) based globally, sourced mainly through direct placements with its strategic partners. This segment also includes business written by Syndicate 3456. Its lines of business include casualty, financial, health, multiline and specialty.

AI analysis of Greenlight Capital Re Ltd (GLRE)

hold

While GLRE's current price of 15.37 is attractive given its low forward P/E of 4.6447, the recent earnings report showing a GAAP EPS of -0.89 and significant insider selling (up 110.82%) suggest caution. The RSI of 40.734 indicates the stock is neither overbought nor oversold, making it a hold for now as we await clearer signals.

Analyst Ratings (3)

Buy
2 Buy
1 Hold
0 Sell
Current: 15.37
Low
Average
High

Valuation Metrics

The current forward P/E ratio for Greenlight Capital Re Ltd (GLRE) is 4.64, compared to its 5-year average forward P/E of 4.39.

Forward P/E

Fair
5Y Average P/E
4.39
Current P/E
4.64
Overvalued
5.38
Undervalued
3.40

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued
0.00
Undervalued
0.00

Forward P/S

Strongly Undervalued
5Y Average P/S
0.00
Current P/S
0.00
Overvalued
0.00
Undervalued
0.00

Alphio AI Price Scenarios for GLRE

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%GLRE

$12.57

Scenario price

B

Base

Base · 50%GLRE

$12.41

Scenario price

B

Bear

Bear · 25%GLRE

$9.46

Scenario price

Whales holding GLRE

C

CWA Asset Management Group, LLC

+ HoldingGLRE

+2.03%

3M Return

GLRE FAQ — answered by Alphio AI

Greenlight Capital Re, Ltd provides multiline property and casualty insurance and reinsurance through its licensed and regulated reinsurance entities in the Cayman Islands and Ireland, and its Lloyd’s platform, Greenlight Innovation Syndicate 3456. The Company’s segments include Open Market and Innovations. In the Open Market segment, the Company underwrites reinsurance business, sourced through the brokerage distribution channels and Lloyd’s. The Company writes treaty reinsurance on a proportional and non-proportional basis. Its lines of business include casualty, financial, health, multiline, property and specialty. In the Innovations segment, the Company provides reinsurance capacity to startup companies and managing general agents (MGAs) based globally, sourced mainly through direct placements with its strategic partners. This segment also includes business written by Syndicate 3456. Its lines of business include casualty, financial, health, multiline and specialty. It operates in the Financials sector (FIRE, MARINE & CASUALTY INSURANCE industry).

While GLRE's current price of 15.37 is attractive given its low forward P/E of 4.6447, the recent earnings report showing a GAAP EPS of -0.89 and significant insider selling (up 110.82%) suggest caution. The RSI of 40.734 indicates the stock is neither overbought nor oversold, making it a hold for now as we await clearer signals.

3 analysts cover GLRE: 2 rate it Buy, 1 Hold and 0 Sell.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started